skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Infarto Do Miocárdio remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A robust prediction model for all forms of acute coronary syndromes estimating the risk of in hospital death and myocardial infarction in the global registry of acute coronary events registry
A robust prediction model for all forms of acute coronary syndromes estimating the risk of in hospital death and myocardial infarction in the global registry of acute coronary events registry
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

A robust prediction model for all forms of acute coronary syndromes estimating the risk of in hospital death and myocardial infarction in the global registry of acute coronary events registry

Kim A. Eagle Michael J Lim; Andrzej Budaj; Omar H Dabbous; Karen Pieper; Shaun G Goodman; Christopher B Granger Steg,Philippe Gabriel; Joel M Gore; Keith Fox; José Antônio Marin-Neto; Annual Scientific Session of American College of Cardiology (52. 2003 New YorK)

Journal of the American College of Cardiology New York supl., p. 353A, res. 810-5, mar, 2003

New York 2003

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 1327972 ) e outros locais(Acessar)

2
Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial
Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial

Manesh R. Patel Kenneth W Mahaffey; Paul W Amstrong; W. Douglas Weaver; Tasissa Gudaye; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Thomas H Parish; Scott Rollins; Pierre Theroux; Wiltold Ruzyllo; José Carlos Nicolau; Cristopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 291A, res. 1118-102, 2004

New York 2004

Localização: FM - Fac. Medicina    (BCSEP 2004 65 ) e outros locais(Acessar)

3
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Item não circula. Consulte sua biblioteca.(Acessar)

4
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial

Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau

Circulation, Baltimore v. 18, p. 1184-1190

Baltimore 2003

Item não circula. Consulte sua biblioteca.(Acessar)

5
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study
Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study

Shaun G. Goodman Jose C Nicolau; Gema Requena; Andrew Maguire; Stefan Blankenberg; Ji Yan Chen; Christopher B Granger; Richard Grieve; Stuart J Pocock; Tabassome Simon; Satoshi Yasuda; Ana Maria Vega; David Brieger

International Journal of Cardiology Clare v. 236, p. 54-60, 2017

Amsterdam 2017

Localização: FM - Fac. Medicina    (BCSEP 011/2017 )(Acessar)

6
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry

Stuart J Pocock David Brieger; John Gregson; Ji Y Chen; Mauricio G Cohen; Shaun G Goodman; Christopher B Granger; Richard Grieve; José Carlos Nicolau; Tabassome Simon

Clinical cardiology v. 43, n. 1, p. 24-32, 2020

Hoboken 2020

Acesso online. A biblioteca também possui exemplares impressos.

7
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial

Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau

Circulation, Baltimore v. 18, p. 1184-1190

Baltimore 2003

Item não circula. Consulte sua biblioteca.(Acessar)

8
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Item não circula. Consulte sua biblioteca.(Acessar)

9
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
Material Type:
Artigo 		Adicionar ao Meu Espaço

Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries

David Brieger Stuart J Pocockb; Stefan Blankenberg; Ji Yan Chen; Mauricio G Cohen; Christopher B Granger; Richard Grieve; Jose Carlos Nicolau; Tabassome Simon; Dirk Westermann

International journal of cardiology v. 311, p. 7-14, 2020

Clare 2020

Acesso online. A biblioteca também possui exemplares impressos.

10
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients insights from the TIGRIS registry
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients insights from the TIGRIS registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients insights from the TIGRIS registry

Juan J Russo Andrew T Yan; Stuart J Pocock; David Brieger; Ruth Owen; Karolina Andersson Sundell; Akshay Bagai; Christopher B Granger; Mauricio G Cohen; Jose Carlos Nicolau

Journal of cardiology v. 79, n. 4, p. 522-529, 2022

Amsterdam 2022

Acesso online. A biblioteca também possui exemplares impressos.

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (3)
  2. Disponível na Biblioteca (6)

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Granger, C
  2. Nicolau, J
  3. Theroux, P
  4. Hochman, J
  5. Ruzyllo, W

Neste Assunto:

  1. Inflamação
  2. Doenças Cardiovasculares
  3. Fatores De Risco
  4. Prognóstico
  5. Resultado De Tratamento

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.